Results of an Open-Label Study to Evaluate the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated with Carboplatin-Containing Chemotherapy in Patients with Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Carcinoma (Stage I-IV) or Papillary Serous Cancer of the Uterus-Reference-Cited by-同舟云学术

Results of an Open-Label Study to Evaluate the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated with Carboplatin-Containing Chemotherapy in Patients with Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Carcinoma (Stage I-IV) or Papillary Serous Cancer of the Uterus

Published:2008-06 Issue:1 Volume:1 Page:60-65
ISSN:1941-4390
Container-title:Clinical Ovarian Cancer
language:en
Short-container-title:Clinical Ovarian Cancer

Author:

Timmins Patrick,Kredentser Daniel,Hancock Kenneth,Messing Mark,Boehm Kristi A.,Mull Stephanie,Asmar Lina

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference49 articles.

1. Integrating aprepitant and palonosetron into clinical practice: a role for the new antiemetics;Viale;Clin J Oncol Nurs,2005

2. Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting;Navari;Expert Rev Anticancer Ther,2004

3. Merck & Co, Inc. Emend® package insert. Issued March 2005.

4. Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin

5. The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials;Warr;Eur J Cancer,2005

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of the oral neurokinin-1 receptor antagonist aprepitant for nausea and vomiting induced by cisplatin and carboplatin in Japanese patients with gynecological cancer;Journal of Obstetrics and Gynaecology Research;2017-07-10

2. Investigating Chemotherapy-Induced Nausea and Vomiting;Clinical Ovarian Cancer;2008-06